Neuronal Androgen Receptor: Molecular Gateway to Polycystic Ovary Syndrome?

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2017 Apr 6

PMID 28377515

Citations 6

Authors

David H Abbott

Affiliations

Soon will be listed here.

Citing Articles

Effects of electroacupuncture on the kisspeptin-gonadotropin-releasing hormone (GnRH) /luteinizing hormone (LH) neural circuit abnormalities and androgen receptor expression of kisspeptin/neurokinin B/dynorphin neurons in PCOS rats.

Xu G, Zhao X, Li Z, Hu J, Li X, Li J J Ovarian Res. 2023; 16(1):15.

PMID: 36650561 PMC: 9844031. DOI: 10.1186/s13048-022-01078-x.

MIAOME: Human microbiome affect the host epigenome.

Wang L, Zhang W, Wu X, Liang X, Cao L, Zhai J Comput Struct Biotechnol J. 2022; 20:2455-2463.

PMID: 35664224 PMC: 9136154. DOI: 10.1016/j.csbj.2022.05.024.

The Mechanism of Androgen Actions in PCOS Etiology.

Rodriguez Paris V, Bertoldo M Med Sci (Basel). 2019; 7(9).

PMID: 31466345 PMC: 6780983. DOI: 10.3390/medsci7090089.

Polycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment With Emphasis on Adolescent Girls.

Witchel S, Oberfield S, Pena A J Endocr Soc. 2019; 3(8):1545-1573.

PMID: 31384717 PMC: 6676075. DOI: 10.1210/js.2019-00078.

Neuroendocrine characteristics of induced pluripotent stem cells from polycystic ovary syndrome women.

Min Z, Zhao Y, Hang J, Ren Y, Tan T, Fan Y Protein Cell. 2018; 10(7):526-532.

PMID: 30535557 PMC: 6588674. DOI: 10.1007/s13238-018-0600-1.

References

Abbott D, Rayome B, Dumesic D, Lewis K, Edwards A, Wallen K . Clustering of PCOS-like traits in naturally hyperandrogenic female rhesus monkeys. Hum Reprod. 2017; 32(4):923-936. PMC: 6251677. DOI: 10.1093/humrep/dex036. View

Fauser B, Tarlatzis B, Rebar R, Legro R, Balen A, Lobo R . Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril. 2011; 97(1):28-38.e25. DOI: 10.1016/j.fertnstert.2011.09.024. View

Dunaif A . Perspectives in Polycystic Ovary Syndrome: From Hair to Eternity. J Clin Endocrinol Metab. 2016; 101(3):759-68. PMC: 4803161. DOI: 10.1210/jc.2015-3780. View

Caldwell A, Middleton L, Jimenez M, Desai R, McMahon A, Allan C . Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models. Endocrinology. 2014; 155(8):3146-59. DOI: 10.1210/en.2014-1196. View

George J, Kakkar R, Marshall J, Scott M, Finkelman R, Ho T . Neurokinin B Receptor Antagonism in Women With Polycystic Ovary Syndrome: A Randomized, Placebo-Controlled Trial. J Clin Endocrinol Metab. 2016; 101(11):4313-4321. DOI: 10.1210/jc.2016-1202. View

Milner T, Hernandez F, Herrick S, Pierce J, Iadecola C, Drake C . Cellular and subcellular localization of androgen receptor immunoreactivity relative to C1 adrenergic neurons in the rostral ventrolateral medulla of male and female rats. Synapse. 2007; 61(5):268-78. DOI: 10.1002/syn.20370. View

Caldwell A, Edwards M, Desai R, Jimenez M, Gilchrist R, Handelsman D . Neuroendocrine androgen action is a key extraovarian mediator in the development of polycystic ovary syndrome. Proc Natl Acad Sci U S A. 2017; 114(16):E3334-E3343. PMC: 5402450. DOI: 10.1073/pnas.1616467114. View

Dumesic D, Akopians A, Madrigal V, Ramirez E, Margolis D, Sarma M . Hyperandrogenism Accompanies Increased Intra-Abdominal Fat Storage in Normal Weight Polycystic Ovary Syndrome Women. J Clin Endocrinol Metab. 2016; 101(11):4178-4188. PMC: 5095243. DOI: 10.1210/jc.2016-2586. View

Skorupskaite K, George J, Anderson R . The kisspeptin-GnRH pathway in human reproductive health and disease. Hum Reprod Update. 2014; 20(4):485-500. PMC: 4063702. DOI: 10.1093/humupd/dmu009. View

10.

Wilson J, Enriori P . A talk between fat tissue, gut, pancreas and brain to control body weight. Mol Cell Endocrinol. 2015; 418 Pt 2:108-19. DOI: 10.1016/j.mce.2015.08.022. View

11.

Dumesic D, Oberfield S, Stener-Victorin E, Marshall J, Laven J, Legro R . Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome. Endocr Rev. 2015; 36(5):487-525. PMC: 4591526. DOI: 10.1210/er.2015-1018. View

12.

Hakim C, Padmanabhan V, Vyas A . Gestational Hyperandrogenism in Developmental Programming. Endocrinology. 2016; 158(2):199-212. PMC: 5413081. DOI: 10.1210/en.2016-1801. View

13.

Wild R, Carmina E, Diamanti-Kandarakis E, Dokras A, Escobar-Morreale H, Futterweit W . Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab. 2010; 95(5):2038-49. DOI: 10.1210/jc.2009-2724. View

14.

Caldwell A, Eid S, Kay C, Jimenez M, McMahon A, Desai R . Haplosufficient genomic androgen receptor signaling is adequate to protect female mice from induction of polycystic ovary syndrome features by prenatal hyperandrogenization. Endocrinology. 2015; 156(4):1441-52. DOI: 10.1210/en.2014-1887. View

15.

Diamanti-Kandarakis E, Mitrakou A, Raptis S, Tolis G, Duleba A . The effect of a pure antiandrogen receptor blocker, flutamide, on the lipid profile in the polycystic ovary syndrome. J Clin Endocrinol Metab. 1998; 83(8):2699-705. DOI: 10.1210/jcem.83.8.5041. View

16.

Cheng X, Jimenez M, Desai R, Middleton L, Joseph S, Ning G . Characterizing the neuroendocrine and ovarian defects of androgen receptor-knockout female mice. Am J Physiol Endocrinol Metab. 2013; 305(6):E717-26. DOI: 10.1152/ajpendo.00263.2013. View

17.

Burt Solorzano C, Beller J, Abshire M, Collins J, McCartney C, Marshall J . Neuroendocrine dysfunction in polycystic ovary syndrome. Steroids. 2011; 77(4):332-7. PMC: 3453528. DOI: 10.1016/j.steroids.2011.12.007. View

18.

Torchen L, Idkowiak J, Fogel N, ONeil D, Shackleton C, Arlt W . Evidence for Increased 5α-Reductase Activity During Early Childhood in Daughters of Women With Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2016; 101(5):2069-75. PMC: 4870855. DOI: 10.1210/jc.2015-3926. View

19.

Walters K . Androgens in polycystic ovary syndrome: lessons from experimental models. Curr Opin Endocrinol Diabetes Obes. 2016; 23(3):257-63. DOI: 10.1097/MED.0000000000000245. View

20.

Ruka K, Burger L, Moenter S . Both Estrogen and Androgen Modify the Response to Activation of Neurokinin-3 and κ-Opioid Receptors in Arcuate Kisspeptin Neurons From Male Mice. Endocrinology. 2015; 157(2):752-63. PMC: 4733114. DOI: 10.1210/en.2015-1688. View